Ayurvedic management of spastic cerebral palsy affected children in comparison to physiotherapy

Not yet recruiting

• Conditions: Spastic diplegic cerebral palsy. Ayurveda Condition: Vata vyadhi, (2) ICD-10 Condition: G800||Spastic quadriplegic cerebral palsy. Ayurveda Condition: Vata vyadhi, (3) ICD-10 Condition: G802||Spastic hemiplegic cerebral palsy. Ayurveda Condition: Vata vyadhi,

• Registration Number: CTRI/2022/02/040295
• Lead Sponsor: Shri Krishna AYUSH University

Brief Summary

Cerebral Palsy is a group of permanent disorders of the development of movement and posture, causing activity limitations that are attributed to non-progressive disturbances that occurred in the developing fetal or infant brain. The Global incidence of CP is 3.6 per 1000 live births. The  prevalence of Spastic Cerebral Palsy in children  in India is 2.95 per 1000 live children. Its worldwide incidence is 2 to 2.5 per 1000 live births.5,6 while in India it is 2-4 per 1000 live birth. Clinical manifestation of Spastic Cerebral palsy is similar to Vata Vyadhi. Therefore in practice it is managed on the same line by Ayurvedic physicians. Basti Chikitsa and use of Rasayana drugs are the treatment of  choice for vatavyadi. Ayurvedic interventions in cerebral palsy on the line of Vata Vyadhi, have given effective results. However very limited RCTs are available on the same. The high incidence of CP, less parent satisfaction for allopathic management, there is acute need of randomized controlled trial. Considering the same this present study has been planned.

Detailed Description

Not available

Study Timeline

• Last Update Posted: 2022-02-14
• Study Start: 2022-02-18

Recruitment & Eligibility

• Status: Not Yet Recruiting
• Sex: All
• Target Recruitment: 62

Inclusion Criteria

• Children of either sex having Spastic cerebral palsy .
• Cases between age group 1 year to 10 years of either gender.
• Either parent should be willing and capable of following instructions.

Exclusion Criteria

• Patients undergoing any other allopathic medication.
• Patients associated with severe or profound mental retardation.
• Children with fixed contractures and deformities affecting stature and gait.
• Children with acute or chronic illness that can interfere the intervention.
• Any other condition, which as per the investigator would jeopardize the outcome of the trial.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
1. Reduction in spasticity and increased use of muscle groups for activity of daily living	Baseline | 30 days | 60 days | 90 days
2. Attaining of motor milestones	Baseline | 30 days | 60 days | 90 days

Secondary Outcome Measures

Name	Time	Method
improvement in quality of life	90 days

Trial Locations

Locations (1)

Ch Brahm Prakash Ayurved Charak Sansthan; 🇮🇳 West, DELHI, India

Ch Brahm Prakash Ayurved Charak Sansthan

🇮🇳West, DELHI, India

Prof Bharat Bhoyar

Principal investigator

9891954426

bharatbhoyar@gmail.com